Nicodrops, Inc. (OTC:NCDP.PK), developer of the world's first drug-free, non-nicotine smoking cessation lozenge, announced today it has formally received approval from the Canadian Food and Drug Administration for their smoking cessation lozenge. The Canadian FDA Approval Drug Identification Number (DIN) 00245097 was issued through the Therapeutic Products Directorate of the Health Canada, FDA. The DIN number now permits Nicodrops to sell its products in the Canadian market (0.022 +266.67% )!.